1. Home
  2. MAIA vs KULR Comparison

MAIA vs KULR Comparison

Compare MAIA & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • KULR
  • Stock Information
  • Founded
  • MAIA 2018
  • KULR 2013
  • Country
  • MAIA United States
  • KULR United States
  • Employees
  • MAIA N/A
  • KULR N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • MAIA Health Care
  • KULR Technology
  • Exchange
  • MAIA Nasdaq
  • KULR Nasdaq
  • Market Cap
  • MAIA 52.7M
  • KULR 55.3M
  • IPO Year
  • MAIA 2022
  • KULR N/A
  • Fundamental
  • Price
  • MAIA $1.98
  • KULR $2.09
  • Analyst Decision
  • MAIA
  • KULR Buy
  • Analyst Count
  • MAIA 0
  • KULR 1
  • Target Price
  • MAIA N/A
  • KULR $1.00
  • AVG Volume (30 Days)
  • MAIA 175.0K
  • KULR 59.3M
  • Earning Date
  • MAIA 11-12-2024
  • KULR 11-13-2024
  • Dividend Yield
  • MAIA N/A
  • KULR N/A
  • EPS Growth
  • MAIA N/A
  • KULR N/A
  • EPS
  • MAIA N/A
  • KULR N/A
  • Revenue
  • MAIA N/A
  • KULR $9,700,738.00
  • Revenue This Year
  • MAIA N/A
  • KULR N/A
  • Revenue Next Year
  • MAIA N/A
  • KULR $86.04
  • P/E Ratio
  • MAIA N/A
  • KULR N/A
  • Revenue Growth
  • MAIA N/A
  • KULR 4.20
  • 52 Week Low
  • MAIA $0.95
  • KULR $0.10
  • 52 Week High
  • MAIA $5.99
  • KULR $1.75
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 45.13
  • KULR 76.01
  • Support Level
  • MAIA $1.93
  • KULR $1.11
  • Resistance Level
  • MAIA $2.63
  • KULR $1.28
  • Average True Range (ATR)
  • MAIA 0.20
  • KULR 0.22
  • MACD
  • MAIA 0.03
  • KULR 0.03
  • Stochastic Oscillator
  • MAIA 37.37
  • KULR 92.65

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

Share on Social Networks: